Trump Administration Retreats from Medicare and Medicaid Funding Threat Over Transgender Youth Care
Trump s HHS abandons threat to withhold – The White House has stepped back from its boldest effort to dismantle gender-affirming medical services for young people across the United States. According to an official document secured by NPR, the Department of Health and Human Services will not move forward with a proposed regulation that would have cut off all Medicare and Medicaid payments to healthcare facilities offering pediatric transgender care.
A Shift in Federal Policy Direction
Centers for Medicare and Medicaid Services representatives provided NPR with a statement clarifying their position: “CMS does not comment on future rulemaking or speculate on potential actions. The Trump Administration rejects ideologically driven surgical interventions on vulnerable children.”
It is worth noting that surgical procedures remain uncommon among transgender individuals under eighteen years old. The proposed regulation would have covered all forms of gender-affirming treatment, which primarily consist of therapeutic counseling and hormonal medications for children.
Expert Analysis of the Decision
Sam Bagenstos, a law professor at the University of Michigan who previously served as general counsel at HHS during the Biden administration, characterized the administration’s reversal as “a victory for people who are defending the rights and interests of trans people.” However, he cautioned that this move does not necessarily signal a broader withdrawal from the Trump administration’s assertive approach to transgender issues.
Bagenstos explained that “conditions of participation” regulations have traditionally served as tools for HHS to require states and medical facilities to satisfy fundamental health and safety requirements. Such standards typically involve ensuring adequate equipment reserves, implementing emergency response procedures, and maintaining appropriate staff-to-patient ratios, he noted.
The proposed rule was unprecedented because it would have prohibited certain kinds of treatments for a certain population. It violates the Medicare Act, which says that Medicare and Medicaid can’t be used to control the practice of medicine within the state.
Legal Concerns and Public Response
The regulation faced significant legal challenges from the outset. Bagenstos pointed out that the rule appeared unlawful on multiple fronts. Specifically, it conflicted with the Medicare Act’s provision that prevents federal programs from dictating how medicine is practiced within individual states, which retain regulatory authority over medical practice.
Under normal procedures, HHS would issue a proposed rule, allow sixty days for public feedback, and then finalize the regulation. In this instance, after introducing the rule in December and gathering over thirty thousand public comments, the administration decided to abandon the effort entirely. The regulation will not become effective for at least the next twelve months.
Both the American Medical Association and the Children’s Hospital Association submitted formal comments recommending that the agency either withdraw or rescind the proposed rule. Numerous prominent U.S. medical organizations maintain that puberty-blocking medications and sex hormones are both safe and effective treatments for transgender adolescents.
State-Level Landscape and Ongoing Pressures
Despite federal developments, gender-affirming care for youth remains prohibited in twenty-seven states following a wave of legislation enacted over recent years. In the remaining twenty-three states, many hospital clinics continue to provide transgender services, though several have closed their doors within the past year due to pressure from the Trump administration.
This pressure has manifested through multiple channels: the abandoned proposed rule, a separate regulation that would prevent federal Medicaid reimbursement for transgender pediatric patients, and a declaration from Health Secretary Robert F. Kennedy Jr. intended to redefine the standard of care. Notably, the press release announcing these actions in December has disappeared from the HHS website, as has the Kennedy declaration document itself.
The Medicaid regulation currently sits in the final review stage and seems poised to take effect within the coming weeks. Meanwhile, a coalition of states led by Democratic governors successfully challenged the Kennedy declaration in federal court in Oregon. The Trump administration has not yet pursued an appeal of that ruling.
Additionally, the Department of Justice has issued both administrative and criminal subpoenas to hospitals requesting complete personal medical records for transgender youth as well as employment documentation for their healthcare providers. Many of these requests have encountered judicial resistance. The administration has also negotiated agreements with hospitals in Texas and Ohio that included creating detransition clinics.
Furthermore, following the Supreme Court’s recent decision permitting states to exclude young transgender girls from sports competitions, the White House released a statement declaring that the ruling “Bolsters President Trump’s Push to El”—highlighting the administration’s continued commitment to its transgender policy agenda even as it adjusts specific tactics.
